Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultrasound-guided triamcinolone acetonide injection with or without Thera-Band training for subacromial bursitis
ChiCTR1800020421Phase 4Completed
- Sponsor
- Wuhan Fourth Hospital
- Start
- Jan 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of triamcinolone acetonide in subacromial bursitis (2 arms), sponsored by Wuhan Fourth Hospital. Primary endpoints: Constant score at week 24 and Visual Analog Scale pain score at week 24. Started Jan 2015; status: completed.
02
Drugs
triamcinolone acetonide
03
Conditions
subacromial bursitis
Beyond the preview
Go deeper on ChiCTR1800020421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800020421.